3 Reasons Growth Investors Will Love CBRE (CBRE)

Zacks Investment Research identifies CBRE Group (CBRE) as a compelling growth stock, assigning it a Growth Score of 'A' and a Zacks Rank #2 (Buy). This positive outlook is driven by CBRE's robust projected EPS growth of 19.4% this year, significantly exceeding the industry average of 2.8%, coupled with strong year-over-year cash flow growth of 23.3% against an industry decline. Additionally, recent upward revisions in current-year earnings estimates, with the Zacks Consensus Estimate rising 4.1% over the past month, further bolster its investment case, positioning CBRE for potential market outperformance.

Analysis

CBRE Group (CBRE) has been identified by Zacks Investment Research as a compelling growth stock, holding a Zacks Rank #2 (Buy) and a Growth Score of 'A'. The positive assessment is underpinned by several key financial metrics that significantly outpace industry averages. Specifically, CBRE's earnings per share (EPS) are projected to grow 19.4% this year, a stark contrast to the real estate investment management services industry's average expected growth of just 2.8%. This forward-looking strength is further supported by robust cash flow generation; the company's year-over-year cash flow growth stands at 23.3%, whereas the industry is facing a contraction with an average of -1.8%. Reinforcing this bullish outlook, there have been positive revisions to earnings estimates, with the Zacks Consensus Estimate for the current year increasing by 4.1% over the past month, a factor that empirically correlates with near-term stock price movements.

Key Decisions for Investors

• Growth-focused investors should consider CBRE a strong candidate for portfolio inclusion, given its combination of a 'Buy' rating and top-tier quantitative scores for growth.
• Investors should closely monitor upcoming earnings releases to verify the company's trajectory towards its projected 19.4% EPS growth, as this is the core pillar of the current investment thesis.
• Pay close attention to the trend in analyst earnings estimate revisions, as the recent 4.1% upward revision is a key cited catalyst for near-term performance; any slowdown or reversal in this trend could be a leading negative indicator.